Results 11 to 20 of about 17,826 (255)
The past, present and future of penile cancer in the Nordic countries. Results from NORDCAN [PDF]
BJUI CompassObjectives This work aims to present epidemiological data on penile cancer from the Nordic region (Denmark, Finland, Iceland, Norway, Sweden) and discuss the results in light of the present knowledge and possible future treatment strategies. Patients and
Christian Arvei Moen +5 more
doaj +2 more sources
Advanced penile cancer with multiple metastases and self-amputation of penis: A rare case report
Urology Case Reports, 2023 Penile cancer is a rare malignancy with poor prognosis. Advanced penile cancer that invades the penile shaft and causes urinary retention could be rarely seen.
Pu Yuan +4 more
doaj +1 more source
Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study
JMIR Public Health and Surveillance, 2022 BackgroundPenile cancer is a relatively rare genital malignancy whose incidence and mortality are rising in many countries. ObjectiveThis study aims to assess the recent incidence and mortality patterns and incidence ...
Leiwen Fu +14 more
doaj +1 more source
Global research trends in penile cancer: Bibliometric and visualized analysis
Frontiers in Oncology, 2023 BackgroundPenile cancer is a malignant tumor of the genitourinary system that mostly occurs in middle-aged and elderly men aged 50–70 years, which can seriously affect physical, psychological, and sexual health.
Sheng Deng +10 more
doaj +1 more source
Penile sparing therapy for penile cancer [PDF]
Translational Andrology and Urology, 2020 Penile cancer is a rare malignancy with a reported incidence of 0.66-1.44 per 100,000 men, and a reported mortality of 0.15-0.37 per 10,000 men. Expert clinical examination and histological diagnosis from biopsy is required to determine the extent and invasion of disease, which is paramount in planning of appropriate treatment.
Yao, Henry Han-I +2 more
openaire +2 more sources
Prognostic Markers and Trials in Penile Cancer
Urology Research and Practice, 2023 New tumor biomarkers open the potential for designing personalized therapy for penile squamous cell carcinoma. Despite the initial promising results of some biomarkers, controversy remains due to contradictory studies.
Naufal Naushad +4 more
doaj +1 more source
Chemotherapy in Penile Cancer [PDF]
Therapeutic Advances in Urology, 2012 Penile cancer is an aggressive disease and after systemic progression it is virtually incurable. While this squamous cell cancer responds to chemotherapy, successful treatment of lymphatic metastases can only be achieved with aggressive surgical treatment in combination with chemotherapy. However, because penile carcinoma is relatively rare there is a
Oliver W. Hakenberg, Chris Protzel
openaire +3 more sources
The Biomarker Potential of Caveolin-1 in Penile Cancer
Frontiers in Oncology, 2021 Various types of human cancers were characterized by an altered expression of epithelial or stromal caveolin-1 (CAV1). However, the clinical significance of CAV1 expression in penile cancer remains largely unknown.
Andrej Panic +6 more
doaj +1 more source
Overexpression of ANXA1 in penile carcinomas positive for high-risk HPVs. [PDF]
PLoS ONE, 2013 The incidence of penile cancer varies between populations but is rare in developed nations. Penile cancer is associated with a number of established risk factors and associated diseases including phimosis with chronic inflammation, human papillomavirus ...
Marilia Freitas Calmon +17 more
doaj +1 more source
Patterns of Treatment and Outcomes in Older Men With Penile Cancer: A SEER Dataset Analysis
Frontiers in Oncology, 2022 PurposeTo evaluate clinicopathologic and treatment characteristics from a population-based cohort of penile cancer, with an emphasis in older adults, due to incomplete evidence to guide therapy in this age subgroup.Materials and MethodsPatients with ...
Maria T. Bourlon +7 more
doaj +1 more source